Vimarsana
Biggest News Aggregation in the World

Page 29 - Foundation Fighting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Foundation Fighting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Foundation Fighting Today - Breaking & Trending Today

Foundation Fighting Blindness Appoints Claire M. Gelfman, Ph.D. as Chief Scientific Officer - Vimarsana News

Foundation Fighting Blindness Appoints Claire M. Gelfman, Ph.D. as Chief Scientific Officer

Share this article COLUMBIA, Md., April 27, 2021 /PRNewswire/ --  Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announces that it has appointed Claire M. Gelfman, Ph.D. as chief scientific officer. In her new role, Dr. Gelfman will be responsible for leading the overarching scientific strategy for the organization with a focus on research initiatives designed to accelerate new treatments and cures for inherited retinal diseases. Additionally, Dr. Gelfman will oversee the Foundation's non-clinical res...

SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics - Vimarsana News

SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics

SparingVision Expands Novel Ocular Disease Pipeline with Acquisition of GAMUT Therapeutics GAMUT rod-cone dystrophies such as retinitis pigmentosa rod-cone dystrophies today - Paris, 202 1 - SparingVision (the "Company"), a genomic medicines company developing vision saving treatments for ocular diseases, today announces it has entered into a definitive agreement to acquire GAMUT Therapeutics ("GAMUT"), a biotechnology company pioneering a unique gene-independent approach to treat the later stages of rod-cone dystrophies such as retinitis pigmentosa ("RP"). The acquisition, subject to leg...

Nate Light, Revered Exec Who Built Sterling, Dies - Vimarsana News

Nate Light, Revered Exec Who Built Sterling, Dies

Share Nathan “Nate” Light (pictured), the affable yet driven executive who helped turn Sterling Jewelers into a retail powerhouse, died on March 12 in Palm Beach, Fla. He was 86. After serving in the U.S. Navy, Light started his industry career as a salesman at Rose Jewelers in Detroit, working for 65 cents an hour. He later became the company’s vice president of merchandising. After that, he worked as a buyer, general manager, and executive vice president at another Detroit jeweler, Shifrin-Willens. In 1977, Light became chairman and CEO of Sterling Jewelers, in a move that proved fate...

Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar - Vimarsana News

Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar

Press release content from PR Newswire. The AP news staff was not involved in its creation. Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar March 2, 2021 GMT (PRNewsfoto/Foundation Fighting Blindness) COLUMBIA, Md., March 2, 2021 /PRNewswire/ -- The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host an online continuing medical education (CME and COPE) course on Monday, April 5, 2021, at 7:00 p.m. Eastern Time. More than 40 clinical trials for emerging retinal de...

Source: apnews.com
SparingVision Conference Participation in H1 2021 - Vimarsana News

SparingVision Conference Participation in H1 2021

SparingVision Conference Participation in H1 2021 SparingVision Conference Participation in H1 2021 Paris, February 16, 2021 - SparingVision ("the Company"), a genomic medicine company developing vision saving treatments for ocular diseases, announces the conferences that its management team will be participating in in the first half of 2021. OIS Gene Therapy Innovation Showcase , 18 February Gene Therapy Outlook panel, Prof. José Alain Sahel, scientific co-founder (2:30-3:30 PM EST) 4th Annual Gene Therapy for Rare Disorders , 22-25 February , Dr Dan Chung, Chief Medical Officer, (Feb 22, 3...